Evidence map›Paper›PMID 30482155›Full record

ArticleBMC genomics2018

A data science approach for the classification of low-grade and high-grade ovarian serous carcinomas.

Sangdi Lin, Chen Wang, Shabnam Zarei, Debra A Bell, Sarah E Kerr, George C Runger, Jean-Pierre A Kocher

Open access · goldAbstract read
In one paragraph

Article in BMC genomics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Antitumor activity of rucaparib plus PLX038A in serous endometrial carcinoma.Journal of experimental & clinical cancer research : CR · 2025
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Sangdi LinSchool of Computing, Informatics, and Decision Systems Engineering, Arizona State University, Tempe, 85281, AZ, USA.
Chen WangDepartment of Health Sciences Research, Mayo Clinic, Rochester, 55905, MN, USA.
Shabnam ZareiDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, 55905, MN, USA.
Debra A BellDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, 55905, MN, USA.
Sarah E KerrDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, 55905, MN, USA.
George C RungerSchool of Computing, Informatics, and Decision Systems Engineering, Arizona State University, Tempe, 85281, AZ, USA.
Jean-Pierre A KocherDepartment of Health Sciences Research, Mayo Clinic, Rochester, 55905, MN, USA. kocher.jeanpierre@mayo.edu.
Mayo Clinic in Arizona · USMayo Clinic in Florida · USArizona State University · USDecision Systems (United States) · US

Funding

Mayo Clinic Ovarian SPORE P50 CA136393
6 · The paper itself

Abstract

backgroundCopy Number Alternations (CNAs) is defined as somatic gain or loss of DNA regions. The profiles of CNAs may provide a fingerprint specific to a tumor type or tumor grade. Low-coverage sequencing for reporting CNAs has recently gained interest since successfully translated into clinical applications. Ovarian serous carcinomas can be classified into two largely mutually exclusive grades, low grade and high grade, based on their histologic features. The grade classification based on the genomics may provide valuable clue on how to best manage these patients in clinic. Based on the study of ovarian serous carcinomas, we explore the methodology of combining CNAs reporting from low-coverage sequencing with machine learning techniques to stratify tumor biospecimens of different grades.

resultsWe have developed a data-driven methodology for tumor classification using the profiles of CNAs reported by low-coverage sequencing. The proposed method called Bag-of-Segments is used to summarize fixed-length CNA features predictive of tumor grades. These features are further processed by machine learning techniques to obtain classification models. High accuracy is obtained for classifying ovarian serous carcinoma into high and low grades based on leave-one-out cross-validation experiments. The models that are weakly influenced by the sequence coverage and the purity of the sample can also be built, which would be of higher relevance for clinical applications. The patterns captured by Bag-of-Segments features correlate with current clinical knowledge: low grade ovarian tumors being related to aneuploidy events associated to mitotic errors while high grade ovarian tumors are induced by DNA repair gene malfunction.

conclusionsThe proposed data-driven method obtains high accuracy with various parametrizations for the ovarian serous carcinoma study, indicating that it has good generalization potential towards other CNA classification problems. This method could be applied to the more difficult task of classifying ovarian serous carcinomas with ambiguous histology or in those with low grade tumor co-existing with high grade tumor. The closer genomic relationship of these tumor samples to low or high grade may provide important clinical value.

Indexed as

DNA Copy Number VariationsGenome, HumanCystadenocarcinoma, SerousData ScienceFemaleHumansNeoplasm GradingOvarian NeoplasmsWhole Genome SequencingClassificationCopy number alternationsData scienceLow-coverage whole genome sequencingMachine learningOvarian serious carcinomaTumor grade

Identifiers

PMID30482155
PMCPMC6258141
OpenAlexW2903086221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.